Correlation Between Takeda Pharmaceutical and JABIL CIRCUIT

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and JABIL CIRCUIT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and JABIL CIRCUIT into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical and JABIL CIRCUIT, you can compare the effects of market volatilities on Takeda Pharmaceutical and JABIL CIRCUIT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of JABIL CIRCUIT. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and JABIL CIRCUIT.

Diversification Opportunities for Takeda Pharmaceutical and JABIL CIRCUIT

-0.59

Correlation Coefficient

Takeda Pharmaceutical  JABIL CIRCUIT

Excellent diversification

The 3 months correlation between Takeda and JABIL is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and JABIL CIRCUIT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on JABIL CIRCUIT and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with JABIL CIRCUIT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of JABIL CIRCUIT has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and JABIL CIRCUIT go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and JABIL CIRCUIT

Assuming the 90 days trading horizon Takeda Pharmaceutical is expected to generate 37.02 times less return on investment than JABIL CIRCUIT. In addition to that, Takeda Pharmaceutical is 1.19 times more volatile than JABIL CIRCUIT. It trades about 0.01 of its total potential returns per unit of risk. JABIL CIRCUIT is currently generating about 0.24 per unit of volatility. If you would invest  12,110  in JABIL CIRCUIT on September 17, 2024 and sell it today you would earn a total of  605.00  from holding JABIL CIRCUIT or generate 5.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Takeda Pharmaceutical  vs.  JABIL CIRCUIT

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

JABIL CIRCUIT

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in JABIL CIRCUIT are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile essential indicators, JABIL CIRCUIT exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Takeda Pharmaceutical and JABIL CIRCUIT

The main advantage of trading using opposite Takeda Pharmaceutical and JABIL CIRCUIT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, JABIL CIRCUIT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JABIL CIRCUIT will offset losses from the drop in JABIL CIRCUIT's long position.

The idea behind Takeda Pharmaceutical and JABIL CIRCUIT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.